Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
LMLeMaitre Vascular, Inc. logo

LeMaitre Vascular, Inc. (LMAT)

NASDAQ Global Market · Currency in USD
$84.45 ▼ -0.88 (-1.03%)
At close: Oct 23, 4:00 PM ET. Market closed.
$84.45 ▲ +0.00 (+0.00%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$85.33
Open
$85.42
Day's Range
$83.94 – $85.42
52 Week Range
$78.22 – $118.01
Volume
184,541
Avg. Volume
331,956
Market Cap
$1.93B
Beta (5Y Monthly)
0.47
PE Ratio (TTM)
29.12
EPS (TTM)
$2.87
Earnings Date
Nov 4, 2026
Forward Dividend & Yield
$1.00 (1.18%)
Ex-Dividend Date
Aug 20, 2026
1y Target Est
$115.00

Profile: LeMaitre Vascular, Inc.

Sector
Healthcare
Industry
Medical - Instruments & Supplies
Full-time employees
651
CEO
George W. LeMaitre

Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi. The company also furnishes carotid shunts, designed to temporarily redirect blood flow to the brain during carotid endarterectomy surgery to clear arterial plaque.

Earnings

Next report: Wed, Nov 4, 2026
EPS estimate $0.69 · Revenue est. $67.39M
DateEst.Actual
Aug 4, 2026$0.81$0.74Miss
May 5, 2026$0.66$0.68Beat
Feb 25, 2026$0.67$0.68Beat
Nov 6, 2025$0.56$0.62Beat
Aug 5, 2025$0.57$0.60Beat
May 1, 2025$0.50$0.48Miss

Analyst view

Consensus price target
$115.00 ▲ +36.2%
Range $95.00 – $135.00
Rating: Buy
Buy 70% · Hold 30% · Sell 0%

Get free alerts on LMAT and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.